Wild-type TTR amyloidosis among patients with unexplained heart failure and systolic LV dysfunction.

Wild-type TTR amyloidosis among patients with unexplained heart failure and systolic LV dysfunction.

<h4>Aim</h4>Transthyretin cardiac amyloidosis (ATTR-CA) is an increasingly recognized cause of heart failure (HF) with preserved left ventricular ejection fraction (LVEF), typically presenting as restrictive cardiomyopathy. The potential co-existence of ATTR-CA with systolic heart failur...

Full description

Bibliographic Details
Main Authors: Sorel Goland, Igor Volodarsky, Yacov Fabricant, Shay Livschitz, Sagi Tshori, Valeri Cuciuc, Liaz Zilberman, Irena Fugenfirov, Valeri Meledin, Sara Shimoni, Sagie Josfberg, Jacob George
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0254104

Internet

https://doi.org/10.1371/journal.pone.0254104

Similar Items